Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC decreased its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 550,812 shares of the company’s stock after selling 22,722 shares during the period. Prestige Consumer Healthcare makes up 2.4% of Rice Hall James & Associates LLC’s investment portfolio, making the stock its 7th largest holding. Rice Hall James & Associates LLC owned 1.12% of Prestige Consumer Healthcare worth $43,013,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Kestra Investment Management LLC acquired a new stake in shares of Prestige Consumer Healthcare in the fourth quarter valued at about $27,000. nVerses Capital LLC lifted its stake in shares of Prestige Consumer Healthcare by 200.0% in the third quarter. nVerses Capital LLC now owns 600 shares of the company’s stock valued at $43,000 after purchasing an additional 400 shares during the period. Huntington National Bank lifted its stake in shares of Prestige Consumer Healthcare by 39.9% in the third quarter. Huntington National Bank now owns 635 shares of the company’s stock valued at $46,000 after purchasing an additional 181 shares during the period. International Assets Investment Management LLC lifted its stake in shares of Prestige Consumer Healthcare by 7,112.5% in the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock valued at $83,000 after purchasing an additional 1,138 shares during the period. Finally, Covestor Ltd increased its holdings in Prestige Consumer Healthcare by 95.6% during the 3rd quarter. Covestor Ltd now owns 1,338 shares of the company’s stock valued at $96,000 after acquiring an additional 654 shares in the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Price Performance

Prestige Consumer Healthcare stock opened at $85.62 on Tuesday. The company has a market cap of $4.23 billion, a price-to-earnings ratio of 20.05, a PEG ratio of 2.43 and a beta of 0.50. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.10 and a current ratio of 3.68. Prestige Consumer Healthcare Inc. has a 1 year low of $62.35 and a 1 year high of $88.36. The firm has a 50 day moving average price of $79.30 and a 200 day moving average price of $76.05.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have weighed in on the stock. DA Davidson raised their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a report on Friday, February 7th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Friday, January 24th. Oppenheimer lifted their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a report on Thursday, February 13th. Canaccord Genuity Group lifted their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Finally, Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $92.60.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.